Reply to “Statins may decrease the Fatality Rate of MERS Infection”

Código QR

Reply to “Statins may decrease the Fatality Rate of MERS Infection”

Guardado en:

Detalles Bibliográficos
Autores principales:	Allison L. Totura, Ralph S. Baric
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2015
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/12830569a8f94f6aa7493194d69199e6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
por: Shu Yuan
Publicado: (2015)

Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
por: David S. Fedson, et al.
Publicado: (2016)

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
por: Allison L. Totura, et al.
Publicado: (2015)

Reply to “Concerns About Misinterpretation of Recent Scientific Data Implicating Dromedary Camels in Epidemiology of Middle East Respiratory Syndrome (MERS)”
por: Abdulaziz N. Alagaili, et al.
Publicado: (2014)

Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection
por: Kun Li, et al.
Publicado: (2020)

Reply to “The Natural Environment May Be the Most Important Source of Antibiotic Resistance Genes”
por: Fabienne Wichmann, et al.
Publicado: (2014)

Reply to “South Asia Instead of Nepal May Be the Origin of the Haitian Cholera Outbreak Strain”
por: Paul S. Keim, et al.
Publicado: (2011)

Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection
por: Courtney E. Comar, et al.
Publicado: (2019)

MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis
por: Vineet D. Menachery, et al.
Publicado: (2017)

Reply to “Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments”
por: Arturo Casadevall, et al.
Publicado: (2014)

Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
por: Jeffrey E. Gold, et al.
Publicado: (2021)

Reply to McDonald, “Protections against the Risk of Airborne SARS-CoV-2 Infection”
por: Leslie Dietz, et al.
Publicado: (2020)

Reply to “The Underestimation of Global Microbial Diversity”
por: Rudolf Amann, et al.
Publicado: (2016)

Reply to “Understanding the Role of Fungi in Chronic Wounds”
por: Lindsay Kalan, et al.
Publicado: (2016)

Reply to “Precedence for the Structural Role of Flagella in Biofilms”
por: Regine Hengge
Publicado: (2013)

Reply to “Triclocarban and Health: the Jury Is Still Out”
por: Lauren Pischel, et al.
Publicado: (2016)

Reply to Drayman, “Observed High Coinfection Rates Seem To Be a Result of Overlapping Plaques”
por: Julie K. Pfeiffer
Publicado: (2017)

Reply to “Comments on Fouchier's Calculation of Risk and Elapsed Time for Escape of a Laboratory-Acquired Infection from His Laboratory”
por: Ron A. M. Fouchier
Publicado: (2015)

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Viroj Wiwanitkit
Publicado: (2016)

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Punya Shrivastava-Ranjan, et al.
Publicado: (2018)

Reply to “Funding by Lottery: Political Problems and Research Opportunities”
por: Arturo Casadevall, et al.
Publicado: (2016)

Emergence of Fatal Avian Influenza in New England Harbor Seals
por: S. J. Anthony, et al.
Publicado: (2012)

Reply to “‘Tolerance’ of Misused Terminology? Enforcing Standardized Phenotypic Definitions”
por: Jakob Haaber, et al.
Publicado: (2015)

Concerns about Misinterpretation of Recent Scientific Data Implicating Dromedary Camels in Epidemiology of Middle East Respiratory Syndrome (MERS)
por: Emad M. Samara, et al.
Publicado: (2014)

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
por: Lily E. Adams, et al.
Publicado: (2021)

Reply to “Unrealistic Nonphysiological Amounts of Reagents and a Disregard for Published Literature”
por: Alistair J. P. Brown
Publicado: (2015)

A Decrease in Transcription Capacity Limits Growth Rate upon Translation Inhibition
por: Qing Zhang, et al.
Publicado: (2020)

Reply to “Conclusive Evidence of Replication of a Plant Virus in Honeybees Is Lacking”
por: Ji Lian Li, et al.
Publicado: (2014)

Reply to “Improving Microbiology Research: the Problems Are Less Statistical and More Biological”
por: Arturo Casadevall, et al.
Publicado: (2016)

Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers
por: David S. Fedson, et al.
Publicado: (2015)

Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
por: Daniel E. Goldberg, et al.
Publicado: (2017)

Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments
por: Nicholas Greig Evans
Publicado: (2014)

Reply to “Concerns about Transmission Electron Micrographs in Recent Article by Chen and Williams”
por: Henry Neal Williams
Publicado: (2012)

Reply to Jobling, “Lysogeny of Escherichia coli by the Obligately Lytic Bacteriophage T1: Not Proven”
por: Leanid Laganenka, et al.
Publicado: (2021)

Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection
por: Sarah E. Hochman, et al.
Publicado: (2015)

Reply to “Studies on Influenza Virus Transmission between Ferrets: the Public Health Risks Revisited”
por: Marc Lipsitch, et al.
Publicado: (2015)

Reply to “Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?”
por: Arturo Casadevall, et al.
Publicado: (2014)

Reply to Vanderberg, “Further Mechanisms and Locations in Which Antisporozoite Antibodies Neutralize Malaria Sporozoites”
por: Photini Sinnis, et al.
Publicado: (2019)

Reply to Hasenkrug et al., “Different Biological Activities of Specific Interferon Alpha Subtypes”
por: Erika Schlaepfer, et al.
Publicado: (2019)

Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
por: Laurence Josset, et al.
Publicado: (2013)